(With Adobe DRM, readable with Adobe Digital Editions for PCs and Macs, and on most mobile devices except Kindle)
For this issue, Dr. Michael Lim of Johns Hopkins and Dr. Isaac Yang of UCSF team up to deliver a packed issue on the latest developments in Immunotherapy. The issue covers hot topics such as immunostimulants, Passive Antibody Mediated Immunotherapy, Clinical Applications of A Peptide Based Vaccine, Challenges for Clinical Design of Immunotherapy Trials, The EGFRv3 Peptide Vaccine, Stem Cell Therapy and Dendritic Cell Vaccines, Dendritic Glioma Fusion Vaccine, Adoptive Cellular Immunotherapy, Virus Mediated Immunotherapy, and so much more.
By Isaac Yang, MD and Michael J Lim, MD, Co-Director, Center for Comprehensive Cardiovascular Care (C4), Director, Division of Cardiology, Professor of Internal Medicine, Jack Ford Shelby Endowed Professor in Cardiology, Director, Cardiac Catheterization Laboratory, Director, Cardiovascular Diseases and Interventional Cardiovascular Diseases Fellowship Programs, Saint Louis University School of Medicine, St. Louis, Missouri
Elsevier is a leading publisher of health science books and journals, helping to advance medicine by delivering superior education, reference information and decision support tools to doctors, nurses, health practitioners and students. With titles available across a variety of media—print, online and mobile, we are able to supply the information you need in the most convenient format.